产品描述:
Rasagiline is an inhibitor of monoamine oxidase B (MAO-B; IC50 = 4.43 nM for rat brain enzyme).{24081} It is selective for MAO-B over MAO-A (IC50 = 412 nM for rat brain enzyme). It inhibits serum and NGF withdrawal-induced apoptosis of PC12 cells when used at concentrations ranging from 0.01 to 100 µM.{24079} Rasagiline inhibits rat brain MAO-B in vivo (ED50 = 0.1 mg/kg).{24081} It reduces cerebral edema in a mouse model of traumatic brain injury.{24079} Rasagiline (0.1 mg/kg) reduces cortical and hippocampal levels of full-length and soluble amyloid precursor protein (APP) in rats and mice. It also reduces α-synuclein-induced substantia nigral neuron loss and improves motor dysfunction in a mouse model of Parkinson’s disease.{61047} Formulations containing rasagiline have been used in the treatment of Parkinson’s disease.